Lung cancer patients display elevated plasma levels of soluble TNF receptor 1 (sTNF-R1), fibrinogen, and C-reactive protein (CRP), as well as reduced albumin, highlighting sustained pro-inflammatory conditions. The gene discussed is CRP; the disease is lung carcinoma.